ResearcherNihon UniversityActive in the last 2 years
Yuya Miura
Matched on ORCID iD 0000-0003-0461-4109; OpenAlex author ID A5072860170. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 3 papers
Papers 5
- Impact of CYP2A6 Genotype on Survival Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Receiving Perioperative S-1 Therapy. Co-author DOI 10.1097/sla.0000000000007152↗
- Comparison of Familial and Sporadic Pancreatic Cancer: Clinicopathological and Genomic Features. Co-author DOI 10.1245/s10434-025-18556-3↗
- ASO Author Reflections: Genomic Features of Familial and Sporadic Pancreatic Cancer. Co-author DOI 10.1245/s10434-025-18624-8↗
- Resectability Status of Pancreatic Cancer Having Tumor Contact with an Aberrant Right Hepatic Artery: Is Upfront Surgery Justified? Co-author DOI 10.1245/s10434-022-11624-y↗
- ASO Author Reflections: Pancreatic Cancer Having Tumor Contact with an Aberrant Right Hepatic Artery Should be Regarded as Technically Resectable but Oncologic… Co-author DOI 10.1245/s10434-022-11639-5↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Teiichi Sugiura · 5 shared papers, 2022–2026 · strength 1.14
- Paper ASO Author Reflections: Genomic Features of Familial and Sporadic Pancreatic Cancer. DOI 10.1245/s10434-025-18624-8↗
- Paper Comparison of Familial and Sporadic Pancreatic Cancer: Clinicopathological and Genomic Features. DOI 10.1245/s10434-025-18556-3↗
- Paper Impact of CYP2A6 Genotype on Survival Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Receiving Perioperativ… DOI 10.1097/sla.0000000000007152↗
- Yukiyasu Okamura · 5 shared papers, 2022–2026 · strength 1.14
- Paper ASO Author Reflections: Genomic Features of Familial and Sporadic Pancreatic Cancer. DOI 10.1245/s10434-025-18624-8↗
- Paper Comparison of Familial and Sporadic Pancreatic Cancer: Clinicopathological and Genomic Features. DOI 10.1245/s10434-025-18556-3↗
- Paper Impact of CYP2A6 Genotype on Survival Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Receiving Perioperativ… DOI 10.1097/sla.0000000000007152↗
- Keiichi Ohshima · 3 shared papers, 2026 · strength 0.84
- Paper ASO Author Reflections: Genomic Features of Familial and Sporadic Pancreatic Cancer. DOI 10.1245/s10434-025-18624-8↗
- Paper Comparison of Familial and Sporadic Pancreatic Cancer: Clinicopathological and Genomic Features. DOI 10.1245/s10434-025-18556-3↗
- Paper Impact of CYP2A6 Genotype on Survival Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Receiving Perioperativ… DOI 10.1097/sla.0000000000007152↗
- Ryo Ashida · 4 shared papers, 2022–2026 · strength 0.79
- Paper Comparison of Familial and Sporadic Pancreatic Cancer: Clinicopathological and Genomic Features. DOI 10.1245/s10434-025-18556-3↗
- Paper Impact of CYP2A6 Genotype on Survival Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Receiving Perioperativ… DOI 10.1097/sla.0000000000007152↗
- Paper Resectability Status of Pancreatic Cancer Having Tumor Contact with an Aberrant Right Hepatic Artery: Is Upfront Surger… DOI 10.1245/s10434-022-11624-y↗
- Katsuhiko Uesaka · 4 shared papers, 2022–2026 · strength 0.79
- Paper Comparison of Familial and Sporadic Pancreatic Cancer: Clinicopathological and Genomic Features. DOI 10.1245/s10434-025-18556-3↗
- Paper Impact of CYP2A6 Genotype on Survival Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Receiving Perioperativ… DOI 10.1097/sla.0000000000007152↗
- Paper Resectability Status of Pancreatic Cancer Having Tumor Contact with an Aberrant Right Hepatic Artery: Is Upfront Surger… DOI 10.1245/s10434-022-11624-y↗
- Katsuhisa Ohgi · 4 shared papers, 2022–2026 · strength 0.79
- Paper Comparison of Familial and Sporadic Pancreatic Cancer: Clinicopathological and Genomic Features. DOI 10.1245/s10434-025-18556-3↗
- Paper Impact of CYP2A6 Genotype on Survival Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Receiving Perioperativ… DOI 10.1097/sla.0000000000007152↗
- Paper Resectability Status of Pancreatic Cancer Having Tumor Contact with an Aberrant Right Hepatic Artery: Is Upfront Surger… DOI 10.1245/s10434-022-11624-y↗
- Kenichi Urakami · 2 shared papers, 2026 · strength 0.48
- Mihoko Yamada · 2 shared papers, 2022 · strength 0.30
- Paper Resectability Status of Pancreatic Cancer Having Tumor Contact with an Aberrant Right Hepatic Artery: Is Upfront Surger… DOI 10.1245/s10434-022-11624-y↗
- Paper ASO Author Reflections: Pancreatic Cancer Having Tumor Contact with an Aberrant Right Hepatic Artery Should be Regarded… DOI 10.1245/s10434-022-11639-5↗
- Yoshiyasu Kato · 1 shared paper, 2026 · strength 0.24
- Ken D Yamaguchi · 1 shared paper, 2026 · strength 0.24
- Takumi Kitahama · 1 shared paper, 2026 · strength 0.24
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.